About ONWARD
ONWARD is a company based in Eindhoven (Netherlands) founded in 2014. ONWARD has raised $35.04 million across 13 funding rounds from investors including Otto Bock, EQT and HHS. ONWARD offers products and services including ARC EX Therapy, ARC IM, and Brain-Computer Interface. ONWARD operates in a competitive market with competitors including SetPoint Medical, Nalu Medical, Atlantic Therapeutics, Synchron and CyMedica Ortho, among others.
- Headquarter Eindhoven, Netherlands
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$35.04 M (USD)
in 13 rounds
-
Latest Funding Round
Not available
-
Investors
Otto Bock
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ONWARD
ONWARD offers a comprehensive portfolio of products and services, including ARC EX Therapy, ARC IM, and Brain-Computer Interface.
Non-invasive device to improve hand function in spinal cord injury patients.
Implantable system for restoring movement in neurological conditions.
Technology for brain-controlled device interaction in paralysis cases.
Funding Insights of ONWARD
ONWARD has successfully raised a total of $35.04M across 13 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ONWARD
ONWARD has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Otto Bock, EQT and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
AI, deeptech, and healthcare tech companies are funded by Inkef.
|
Locked | Locked | Locked | |
|
Infrastructure and venture capital funding is provided in key sectors.
|
Locked | Locked | Locked |
Investor details for ONWARD
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ONWARD
Investment portfolio details for ONWARD
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ONWARD
Detailed financials for ONWARD
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Onward Comparisons
Peer comparison for ONWARD
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ONWARD
ONWARD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SetPoint Medical, Nalu Medical, Atlantic Therapeutics, Synchron and CyMedica Ortho, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable neuromodulation devices are developed for inflammatory diseases.
|
|
| Locked | Locked | Locked |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| Locked | Locked | Locked |
Non-invasive wearable devices for pelvic floor strengthening are developed.
|
|
| Locked | Locked | Locked |
Implantable bioelectronics are developed for neurological condition treatments.
|
|
| Locked | Locked | Locked |
Neuromuscular electrical stimulation platform to prevent Muscle atrophy after orthopedic surgeries
|
Detailed competitors of ONWARD
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Onward
Complete news archive for ONWARD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ONWARD
ONWARD was founded in 2014.
ONWARD is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.
Dave Marver is the current CEO of ONWARD.
ONWARD is a funded company, having raised a total of $35.04M across 13 funding rounds to date.
ONWARD was founded in 2014 in Eindhoven, Netherlands, and operates in the medical device sector. Focus is placed on developing ARC therapy, which is delivered through implantable or external systems. Programmed stimulation of the spinal cord is utilized to restore movement and associated functions in patients with spinal cord injuries. Operations center on therapeutic innovation for neurological conditions.
ONWARD's top competitors include SetPoint Medical, Synchron and Nalu Medical.
ONWARD offers ARC EX Therapy, ARC IM, and Brain-Computer Interface.
ONWARD has 13 investors. Key investors include Otto Bock, EQT, HHS, Gimv, and European Union.